Recruiting

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.

ClinicalTrials.gov IDNCT06694012
PhaseNot Applicable
Enrollment2000
SponsorOsaka Metropolitan University
Age20 Years and older
SexALL
I'm interested View official listing

Conditions studied

Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension, Hyperglycemia, Hyperlipidemia, Dyslipidemia, Hyperuricemia or Gout, Hyperuricemia, Gout, Obesity, Obesity/Epidemiology, Obesity, Abdominal, Central Obesity, Visceral Fat, Chronic Kidney Disease(CKD), Atherosclerosis, Metabolic Syndrome, Hepatic Steatosis, Insulin Sensitivity/Resistance

About this study

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.

Primary outcomes

Eligibility information

Inclusion Criteria: \- Exclusion Criteria: * Women who may be pregnant

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-13.